Ftse Mib
33.758,43
-1,27%
DAX
19.189,19
-0,16%
S&P 500
5.893,62
0,39%
NASDAQ
18.791,81
0,60%
Bitcoin
91.410,82
0,96%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Larimar Therapeutics Inc (LRMR) Larimar Therapeutics Inc (LRMR) Notizie

Larimar Therapeutics Inc

LRMR
6,16
-0,53 (-7,92%)
19 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/11/202413:02EDGAR2Form 8-K - Current report
14/11/202423:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202415:16EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/10/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202412:03EDGAR2Form 8-K - Current report
08/8/202420:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202413:02EDGAR2Form 8-K - Current report
10/6/202412:05EDGAR2Form 8-K - Current report
31/5/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202422:07EDGAR2Form 8-K - Current report
30/5/202422:08EDGAR2Form 8-K - Current report
28/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
20/5/202422:08EDGAR2Form 8-K - Current report
09/5/202422:50EDGAR2Form S-3 - Registration statement under Securities Act of..
09/5/202413:02EDGAR2Form 8-K - Current report
11/3/202421:09EDGAR2Form 8-K - Current report
16/2/202422:06EDGAR2Form 8-K - Current report
15/2/202402:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202423:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202414:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202412:06EDGAR2Form 8-K - Current report
13/2/202422:46EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/2/202413:03EDGAR2Form 8-K - Current report
19/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 6,53 Min: 5,9622 Max: 6,62
Chiusura: 6,69

La tua Cronologia

NASDAQ
LRMR
Larimar Therapeutics
TG
M3BK
Mic
LSE
SAVE
Savannah Energy
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network